Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
Clinical trial NCT03449238 · RECRUITING
Trial details
- NCT number
- NCT03449238
- Sponsor
- Weill Medical College of Cornell University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-15
- Primary completion
- 2028-12-31
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.